Biden administration adds injectable PrEP requirement for insurance providers
The Biden-Harris administration has announced a new requirement for insurance providers to cover injectable PrEP in their policies without a co-payment for consumers. The new rule, built on previous guidance for the Affordable Care Act, also applies to increased choice in contraception. The Biden-Harris administration announced Monday a new requirement for insurance providers to cover injectable PrEP in their policies without a co-payment for consumers. PrEP, or pre-exposure prophylaxis, was first approved by the FDA in 2012 to prevent people exposed to HIV from becoming infected with the virus. Truvada in pill form was the first prescriptive PrEP to hit the market, followed by Descovy. The injectable PrEP Apretude was approved in 2021.








